Search
Australia's TGA Guidance Blog: Labelling and Presentation Requirements for Listed Medicines
On 9 April 2025, the Therapeutic Goods Administration (TGA) released updated guidance titled “ Understanding Labelling and Presentation...

Sharan Murugan
11 minutes ago3 min read
1 view
0 comments


SFDA Guidance: Requirements for Formal Meetings Between the Drug Sector and Applicants
Th e Saudi Food and Drug Authority (SFDA)Â has issued an updated version (3.1, dated 7 April 2025) of its guideline: " Requirements for...

Sharan Murugan
38 minutes ago2 min read
1 view
0 comments


ICH Guidance Q1: Stability Testing of Drug Substances and Drug Products (Step 2 Draft 2025)- Public Consultation
The International Council for Harmonisation (ICH) has released a significant update to its stability testing guidelines, consolidating...

Sharan Murugan
5 days ago2 min read
43 views
0 comments


EMA Guidance: Anonymisation and Confidentiality in Risk Management Plans (RMPs)
The European Medicines Agency (EMA)Â has published a revised guideline titled " Guidance on the Anonymisation of Protected Personal Data...

Sharan Murugan
5 days ago4 min read
8 views
0 comments


EMA Guidance: Procedural Advice on Paediatric Applications
The European Medicines Agency (EMA) has issued updated guidance " Procedural advice on Paediatric Applications " to support stakeholders...

Sharan Murugan
5 days ago3 min read
4 views
0 comments


UK MHRA Guidance: Risk Minimisation Measures for Medicines
The Medicines and Healthcare products Regulatory Agency (MHRA)Â has published updated guidance on " Risk Minimisation Measures (RMMs)Â for...

Sharan Murugan
5 days ago2 min read
4 views
0 comments


EMA Draft Guideline: Quality Aspects of mRNA Vaccines
The European Medicines Agency (EMA) has released a draft guideline outlining " Quality standards for mRNA Vaccines " , f ocusing on...

Sharan Murugan
Apr 82 min read
22 views
0 comments


SAHPRA Guideline: Section 21 Access to Unregistered Medicines
The South African Health Products Regulatory Authority (SAHPRA)Â has updated its Guideline " Section 21 Access to Unregistered Medicines "...

Sharan Murugan
Apr 63 min read
41 views
0 comments


Swissmedic’s Guidance: Packaging, Prior Notification Procedures, Fast-Track Authorisation, Regulatory Meetings & Temporary Authorisations
Swissmedic, the Swiss Agency for Therapeutic Products, has released multiple updated guidance documents in April 2025 that impact...

Sharan Murugan
Apr 62 min read
9 views
0 comments


EMA’s Reflection Paper: Linking to ePI from EU Medicine Packages – A Digital Leap in Patient Information
The European Medicines Agency (EMA) published on 31 March 2025 a draft " Reflection paper on linking to electronic Product Information...

Sharan Murugan
Apr 54 min read
19 views
0 comments


UK MHRA Guidance: National Assessment Procedure for Medicines, Submission and Assessment timetables for Innovative Medicines Applications
The Medicines and Healthcare Products Regulatory Agency (MHRA)Â has introduced a " National Assessment Procedure for Medicines " Â for...

Sharan Murugan
Apr 32 min read
30 views
0 comments


UK MHRA Guidance: Periodic Safety Update Reports (PSURs) for Medicinal Products
Ensuring the ongoing safety and efficacy of medicinal products is a cornerstone of pharmacovigilance. In the United Kingdom, the...

Sharan Murugan
Apr 13 min read
32 views
0 comments


UK MHRA: Guidance for Established Medicines -Marketing Authorisation Application Changes
The regulatory landscape for pharmaceuticals is constantly evolving, and the UK Medicines and Healthcare products Regulatory Agency...

Sharan Murugan
Apr 12 min read
21 views
0 comments


EMA's New AI Work Plan: Shaping the Future of Medicines Regulation
The European Medicines Agency (EMA) has unveiled a comprehensive Artificial Intelligence (AI) Work Plan  to guide the integration of AI...

Sharan Murugan
Mar 312 min read
26 views
0 comments


USFDA Guidance: Study Data Technical Conformance Guide – Technical Specifications Document and Data Standards Catalog
The U.S. Food and Drug Administration (FDA) has released the latest version (v6.0) of the Study Data Technical Conformance Guide in...

Sharan Murugan
Mar 303 min read
59 views
0 comments


UK MHRA Guidance: Blue Guide -Advertising and Promoting Medicines – A Regulatory Overview
The UK Medicines and Healthcare Products Regulatory Agency (MHRA)Â has updated the Appendix 4 Best Practice Guidance of the " Blue Guide:...

Sharan Murugan
Mar 302 min read
15 views
0 comments


MHRA Guidance: Registering to Manufacture, Import, or Distribute Active Substances
The Medicines and Healthcare products Regulatory Agency (MHRA)Â has established guidelines " Medicines: Register to manufacture, import...

Sharan Murugan
Mar 262 min read
26 views
0 comments


USFDA Announcement: Facility Fee Rates for OTC Monograph Drug User Fee Program (OMUFA) for FY 2025
The U.S. Food and Drug Administration (FDA)Â has announced the release of " Over-the-Counter Monograph Drug User Fee Program-Facility Fee...

Sharan Murugan
Mar 212 min read
72 views
2 comments


EMA User Guide: For Micro, Small, and Medium-Sized Enterprises (SMEs)
The European Medicines Agency (EMA)Â has released a " User Guide for Micro, Small, and Medium-Sized Enterprises (SMEs) "Â to help...

Sharan Murugan
Mar 182 min read
18 views
0 comments


SAHPRA Regulatory Information Management System (RIMS): Cancellation of Health Product Registrations for Non-eCTDs
The South African Health Products Regulatory Authority (SAHPRA)Â has issued a Communication to the industry " Regulatory Information...

Sharan Murugan
Mar 162 min read
24 views
0 comments